Goldman Sachs has initiated coverage on UnitedHealth Group Inc (UNH) with a Buy rating, marking its first assessment of the health care giant's investment potential. This action, taken on October 13, 2025, aligns with the firm's analysis of UnitedHealth's business model and growth prospects within the health care industry.
Headquartered in Eden Prairie, Minnesota, UnitedHealth Group engages in providing health care coverage, software, and data consultancy services. With a market capitalization of $287.4 billion, the company reported a trailing twelve-month price-to-earnings ratio of 16.34 and earnings per share of 19.17. The firm operates through segments including Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which encompasses various health care solutions.
Upcoming earnings reports are set for July 26, 2026, with an estimated EPS of $4.37 and revenue of $117.7 billion, followed by another report on April 14, 2026, where EPS is estimated at $6.41 and revenue at $114.5 billion.
Analyst ratings offer valuable insights but should be considered alongside other factors such as company fundamentals and market conditions. As of November 1, 2025, the consensus among analysts remains a Buy, with 7 Strong Buy, 16 Buy, 8 Hold, 2 Sell, and 1 Strong Sell ratings. The recent initiation by Goldman Sachs underscores the ongoing interest in UnitedHealth's robust position in the health care sector.